# Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

> **NCT06448793** · — · RECRUITING · sponsor: **Bristol-Myers Squibb** · enrollment: 55 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer (NSCLC)

## Interventions

- **DRUG:** Approved Non-small Cell Lung Cancer (NSCLC) therapies

## Key facts

- **NCT ID:** NCT06448793
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-25
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06448793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06448793, "Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06448793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*